OTCMKTS:BMXMF - BioMerieux Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$77.20 -0.35 (-0.45 %)
(As of 02/20/2019 02:34 AM ET)
Previous Close$77.55
Today's Range$77.20 - $77.20
52-Week Range$60.50 - $95.05
Volume10 shs
Average Volume300 shs
Market Capitalization$9.14 billion
P/E Ratio33.86
Dividend YieldN/A
bioMérieux S.A. provides vitro diagnostic solutions systems for private and hospital laboratories, primarily for the diagnosis of infectious diseases. The company offers microbiology technology that involves culturing biological samples; and immunoassays technology based on antigen-antibody reaction, detects and measures infectious agents, such as bacteria, viruses, and parasites, as well as measures the specific biomarkers of various pathologies, such as metabolic, hormonal, infectious, etc. It also provides molecular biology for the detection of genetic sequences of deoxyribonucleic acid or ribonucleic acid; and companion diagnostic test based on biomarkers, as well as services for clinical and industrial laboratories. The company was formerly known as B-D Mérieux. bioMérieux S.A. was founded in 1963 and is based in Marcy l'Etoile, France. bioMérieux S.A. is a subsidiary of Institut Mérieux SA.

Receive BMXMF News and Ratings via Email

Sign-up to receive the latest news and ratings for BMXMF and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Private households



Sales & Book Value

Annual Sales$2.58 billion
Book Value$16.58 per share



Market Cap$9.14 billion
OptionableNot Optionable

BioMerieux (OTCMKTS:BMXMF) Frequently Asked Questions

What is BioMerieux's stock symbol?

BioMerieux trades on the OTCMKTS under the ticker symbol "BMXMF."

When is BioMerieux's next earnings date?

BioMerieux is scheduled to release their next quarterly earnings announcement on Wednesday, February 27th 2019. View Earnings Estimates for BioMerieux.

Has BioMerieux been receiving favorable news coverage?

News headlines about BMXMF stock have trended somewhat negative this week, according to InfoTrie Sentiment. The research group rates the sentiment of press coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. BioMerieux earned a media sentiment score of -1.0 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the stock's share price in the next few days.

Who are some of BioMerieux's key competitors?

Who are BioMerieux's key executives?

BioMerieux's management team includes the folowing people:
  • Mr. Alexandre Mérieux, Chairman & CEO (Age 45)
  • Mr. Guillaume Bouhours, Exec. VP & CFO (Age 43)
  • Sylvain Morgeau, Investor Relations
  • Ms. Valérie Leyldé, Exec. VP of HR and Communications
  • Mr. Michel Baguenault, Exec. VP & Company Sec.

How do I buy shares of BioMerieux?

Shares of BMXMF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is BioMerieux's stock price today?

One share of BMXMF stock can currently be purchased for approximately $77.20.

How big of a company is BioMerieux?

BioMerieux has a market capitalization of $9.14 billion and generates $2.58 billion in revenue each year. The company earns $269.23 million in net income (profit) each year or $2.28 on an earnings per share basis. BioMerieux employs 10,800 workers across the globe.

What is BioMerieux's official website?

The official website for BioMerieux is http://www.biomerieux.com.

How can I contact BioMerieux?

BioMerieux's mailing address is 376 CHEMIN DE L`ORME, MARCY L`ETOILE I0, 69280. The company can be reached via phone at 33-4-78-87-20-00 or via email at [email protected]

MarketBeat Community Rating for BioMerieux (OTCMKTS BMXMF)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  64 (Vote Outperform)
Underperform Votes:  62 (Vote Underperform)
Total Votes:  126
MarketBeat's community ratings are surveys of what our community members think about BioMerieux and other stocks. Vote "Outperform" if you believe BMXMF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BMXMF will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/20/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel